Your browser doesn't support javascript.
loading
The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis.
Wu, Yuan; Huang, Mengfen; Zhong, Jinyao; Lu, Yue; Gan, Kao; Yang, Rongyuan; Liu, Yuntao; Li, Jiqiang; Chen, Jiankun.
Afiliação
  • Wu Y; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Huang M; Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhong J; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Lu Y; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Gan K; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
  • Yang R; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Liu Y; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
  • Li J; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Chen J; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Front Immunol ; 14: 1089710, 2023.
Article em En | MEDLINE | ID: mdl-37114057

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Suíça